MedPath

Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients

Not yet recruiting
Conditions
Alzheimer Disease
Mini-Mental State Examination
Cognitive Dysfunction
Neuropsychological Tests
Caregivers
Registration Number
NCT07122856
Lead Sponsor
Centre Hospitalier de Gonesse
Brief Summary

This study looks at people with Alzheimer's disease to find out which factors are linked to their initial score on the Mini-Mental State Examination (MMSE) and which factors may predict a fast decline in their score over 12 months. Researchers will review medical records from patients seen at the Memory Clinic of Gonesse Hospital and analyze information such as age, education, medical history, nutrition, mood, and caregiver burden. The goal is to better understand what influences early cognitive performance and how quickly it changes, to help improve patient care and planning.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Confirmed diagnosis of Alzheimer's disease according to NIAA 2018 or IWG 2021 criteria
  • At least two MMSE evaluations spaced 12 months apart
  • Follow-up at the Memory Clinic of CH Gonesse
Exclusion Criteria
  • Presence of other neurodegenerative diseases (e.g., Frontotemporal Dementia, Multiple System Atrophy, Vascular Dementia, LATE)
  • Patient has moved out of the study area (outside the CH Gonesse territory)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in MMSE Score Over 12 Months - measured as either a decrease of ≥3 points on the Mini-Mental State Examination [MeSH] or patient institutionalization within 12 months.12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Hospitalier de Gonesse

🇫🇷

Gonesse, France

Centre Hospitalier de Gonesse
🇫🇷Gonesse, France
Abdullah Blakime
Contact
01.34.53.24.64
coordination.rechercheclinique@ghtpdfr.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.